Improving the performance status in advanced non-small cell lung cancer patients with chemotherapy (ImPACt trial): a phase 2 study

被引：0
|
作者：
Neha Pathak
Rakesh Garg
Sachin Khurana
Sudhir Kumar
Akash Kumar
Deepam Pushpam
Maroof Ahmad Khan
Anant Mohan
Sushmita Pathy
Mukesh Yadav
Chandra Prakash Prasad
Prabhat Singh Malik
机构：
[1] All India Institute of Medical Sciences (AIIMS),Department of Medical Oncology
[2] All India Institute of Medical Sciences (AIIMS),Department of Anesthesiology, Critical Care, Pain and Palliative Medicine
[3] All India Institute of Medical Sciences (AIIMS),Department of Bio
[4] All India Institute of Medical Sciences (AIIMS),Statistics
[5] All India Institute of Medical Sciences (AIIMS),Department of Pulmonary Medicine and Sleep Disorders
[6] All India Institute of Medical Sciences (AIIMS),Department of Radiation Oncology
[7] Vardhaman Mahavir Medical College and Safdarjung Hospital,Department of Radiology
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Carcinoma; Non-small-cell lung; Quality of life; Poor performance status; Paclitaxel; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：6399 / 6409
页数：10
相关论文
共 50 条
  • [1] Improving the performance status in advanced non-small cell lung cancer patients with chemotherapy (ImPACt trial): a phase 2 study
    Pathak, Neha
    Garg, Rakesh
    Khurana, Sachin
    Kumar, Sudhir
    Kumar, Akash
    Pushpam, Deepam
    Khan, Maroof Ahmad
    Mohan, Anant
    Pathy, Sushmita
    Yadav, Mukesh
    Prasad, Chandra Prakash
    Malik, Prabhat Singh
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (09) : 6399 - 6409
  • [2] Chemotherapy for advanced non-small cell lung cancer patients with performance status 2
    Blackhall, FH
    Bhosle, J
    Thatcher, N
    CURRENT OPINION IN ONCOLOGY, 2005, 17 (02) : 135 - 139
  • [3] Improving chemotherapy for patients with advanced non-small cell lung cancer
    von Plessen, Christian
    CLINICAL RESPIRATORY JOURNAL, 2011, 5 (01): : 60 - 61
  • [4] Role of chemotherapy in patients with poor performance status and advanced non-small cell lung cancer
    Langer, C
    Lilenbaum, R
    SEMINARS IN ONCOLOGY, 2004, 31 (06) : 8 - 15
  • [5] A Phase I Study of Gemcitabine and Carboplatin in Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2
    Kim, Young Hak
    Kubota, Kaoru
    Goto, Koichi
    Yoh, Kiyotaka
    Niho, Seiji
    Ohmatsu, Hironobu
    Saijo, Nagahiro
    Nishiwaki, Yutaka
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (09) : 576 - 581
  • [6] Erlotinib and bevacizumab in chemotherapy-naive performance status 2 patients with advanced non-small cell lung cancer
    Al Baghdadi, T.
    Hanna, N.
    Bhatia, S.
    McClean, J.
    Johnson, C.
    Yu, M.
    Taber, D.
    Harb, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Chemotherapy in patients with advanced non-small cell lung cancer
    Price, A
    CLINICAL ONCOLOGY, 2001, 13 (06) : 480 - 482
  • [8] Two schedules of chemotherapy for patients with non-small cell lung cancer in poor performance status: a phase II randomized trial
    Zwitter, Matjaz
    Kovac, Viljem
    Rajer, Mirjana
    Vrankar, Martina
    Smrdel, Uros
    ANTI-CANCER DRUGS, 2010, 21 (06) : 662 - 668
  • [9] Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2
    Lilenbaum, Rogerio
    Axelrod, Rita
    Thomas, Sachdev
    Dowlati, Afshin
    Seigel, Leonard
    Albert, Donald
    Witt, Karsten
    Botkin, David
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (06) : 863 - 869
  • [10] Observing who performance status of patients undergoing chemotherapy for advanced non-small cell lung cancer (NSCLC)
    van den Borne, Ben
    Bischoff, Helge G.
    Langer, Frank
    Leschinger, Monika, I
    Moneley, Ciara
    Pimentel, Francisco
    Riska, Henrik
    Szczepura, Ala
    Thatcher, Nicholas
    Thomas, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S454 - S455
12345